80 FR 105 pg. 31384 - Disease, Disability, and Injury Prevention and ControlSpecial Emphasis Panel (SEP): Initial Review
Type: NOTICEVolume: 80Number: 105Page: 31384
Page: 31384FR document: [FR Doc. 2015-13315 Filed 6-1-15; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and ControlSpecial Emphasis Panel (SEP): Initial Review
In accordance with section 10(a)(2) of the Federal AdvisoryCommittee Act (Pub. L. 92-463), the Centers for DiseaseControl and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA), IP-11-00100501PPHF15, PPHF-2015-Enhanced Surveillance for New Vaccine Preventable Disease-A ProgramExpansion for Acute Respiratory Illness Surveillance FinancedSolely by 2015 Prevention and Public Health Funds.
Time and Date: 10:00 a.m.-3:00 p.m., June 23, 2015 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initialreview, discussion, and evaluation of applications received inresponse to "PPHF-2015-Enhanced Surveillance for New VaccinePreventable Disease-A Program Expansion for Acute RespiratoryIllness Surveillance Financed Solely by 2015 Prevention andPublic Health Funds", IP-11-00100501PPHF15.
Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director,Management Analysis and Services Office,Centers for Disease Control and Prevention.
[FR Doc. 2015-13315 Filed 6-1-15; 8:45 am]
BILLING CODE 4163-18-P